Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Publication year range
1.
Med Mycol ; 54(5): 471-7, 2016 Jul 01.
Article in English | MEDLINE | ID: mdl-26868904

ABSTRACT

Bloodstream infections caused by Candida species are of increasing importance and associated with significant mortality. We performed a multi-centre prospective observational study to identify the species and antifungal susceptibilities of invasive bloodstream isolates of Candida species in the Asia-Pacific region. The study was carried out over a two year period, involving 13 centers from Brunei, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. Identification of Candida species was performed at each study center, and reconfirmed at a central laboratory. Susceptibility testing was performed using a commercial broth dilution panel (Sensititre YeastOne YST-010, Thermofisher, United Kingdom) with susceptibility categorisation (S = susceptible, S-DD = susceptible dose-dependent) applied using breakpoints from the Clinical Laboratory Standards Institute. Eight hundred and sixty-one Candida isolates were included in the study. The most common species were C. albicans (35.9%), C. tropicalis (30.7%), C. parapsilosis (15.7%), and C. glabrata (13.6%). Non-albicans species exceeded C. albicans species in centers from all countries except Taiwan. Fluconazole susceptibility was almost universal for C. albicans (S = 99.7%) but lower for C. tropicalis (S = 75.8%, S-DD = 6.1%), C. glabrata (S-DD = 94.9%), and C. parapsilosis (S = 94.8%). Echinocandins demonstrated high rates of in vitro susceptibility (S>99%) against C. albicans, C. tropicalis, and C. parapsilosis This study demonstrates that non-albicans species are the most common isolates from bloodstream infections in most countries in the Asia-Pacific region, with C. tropicalis as the predominant species. Because of the prevalence of reduced susceptibility to fluconazole in non-albicans species, the study indicates that echinocandins should be the antifungal of choice in clinically unstable or high-risk patients with documented candidemia.


Subject(s)
Antifungal Agents/pharmacology , Candida/classification , Candida/drug effects , Candidemia/microbiology , Asia, Southeastern/epidemiology , Candida/isolation & purification , Candidemia/epidemiology , Humans , Microbial Sensitivity Tests , Prevalence , Prospective Studies
2.
Article in Vietnamese | WPRIM (Western Pacific) | ID: wpr-4429

ABSTRACT

Antibiotic resistance of some strains of bacteria isolated at Bach Mai hospital in the year 2003 was evaluated. Each bacterian species was showed on its table: S.aureus in table 1, Enterococci in table 2, S.pneumoniae in table 3, H.influenzae in table 4, P.aeruginosa in table 5, E.coli in table 6, K.pneumonia in table 7, E.cloacae in table 8, P.mirabilis in table 9, S.flexneri in table 10. B.cepacia in table 11 and A.baumannii in table 12.


Subject(s)
Drug Resistance, Microbial , Bacteria , Anti-Bacterial Agents
SELECTION OF CITATIONS
SEARCH DETAIL
...